Shi Y, Lu H, Zhang Y. Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat 2024 Apr 24. doi: 10.1007/s10549-024-07317.
PMID: 38658447